HB2 sparked an NC uproar, but Trump's transgender targeting? Crickets
This coming week will mark nine years since the Charlotte City Council approved a nondiscrimination ordinance that drove Republican state lawmakers to respond with the notorious House Bill 2, also known as the 'bathroom bill.'
The Charlotte ordinance allowed transgender people to use public bathrooms that conformed with their gender identity. House Bill 2, passed a month later, required that transgender people use bathrooms in schools and state and local government facilities that match the sex listed on their birth certificate.
HB2's opponents condemned the law as codifying discrimination against transgender people. The bill, signed into law by Gov. Pat McCrory, sparked wide protests, national news coverage and boycotts that led to an estimated $3.7 billion in lost business. It also contributed to McCrory's narrow loss when he stood for reelection that fall.
HB2 was a spectacular social issue misstep by state Republicans, who supported a repeal of the law one year later.
But, oh, what a difference nine years make. Included in President Trump's fusillade of executive orders have been several targeting transgender people. They restrict transgender people from serving in the military, block gender-affirming medical care for minors and ban transgender athletes from women's and girls' sports.
Trump's orders have triggered lawsuits, but generally the response from Democrats has been silence and even the LGBTQ community seems uncertain about how to protest. Certainly the corporations and athletic organizations that boycotted over HB2 are staying miles away this time.
What happened?
For one, Democrats saw their presidential candidate, Kamala Harris, get hammered by an ad in which she supported taxpayer-funded gender-affirming care for federal prisoners as required by law. State Sen. Dan Blue, who led a walkout by Senate Democrats when HB2 came up for a vote in 2016, said the ad has 'created an environment so toxic that nobody is entering into it.'
Another reason for the muted response is that Republicans switched their attacks on transgender people from being about the supposed danger of 'men in women's bathrooms' to being about fairness in women's sports and protecting children from medical treatments they might regret as adults.
Matt Mercer, a spokesman for the North Carolina Republican Party, said the lack of HB2-style protests to Trump's orders shows that the Republicans were right all along.
'It's a vindication that North Carolina legislators were right to confront this issue, and it's unfortunate that it took seeing women athletes injured or defeated to raise the alarms that biological males do not belong in women's spaces or sports,' Mercer said. 'This is a 70/30 (polling) issue right now because it's rooted in what most people believe to be right versus wrong.'
Republicans effectively recast the transgender issue, said Chris Cooper, a political scientist at Western Carolina University. 'They transitioned to a popular position. It's Politics 101.' But he said a broad restriction of transgender rights is still an unpopular move. 'I still think HB2 would go down today, or wouldn't be introduced in the first place,' he said.
Trump's executive orders come after state Republican lawmakers passed similar restrictions in recent years. Eliazar Posada, executive director of the LGBTQ advocacy group Equality North Carolina, said the drumbeat against transgender people has left some would-be protesters exhausted and numb. But as the significance of Trump's orders sink in, he said, resistance is stirring.
'It has become so common to see trans folks and LGBTQ folks attacked in many different ways that for some it's just become run of the mill,' he said. But lately, he added, 'There's quite a bit of uproar. We may not see it in policymakers and the media, but we're seeing it in the community.'
State Rep. Marcia Morey, a Durham Democrat, said post-election worries that Democrats went too far in support of transgender rights has left a vulnerable group of people on their own. 'There are a lot of frightened people in need of medical and psychiatric help who are transitioning who are being forgotten now,' she said.
Given the muted response to Trump's targeting transgender people, I asked Morey if state Senate leader Phil Berger might consider bringing HB2 back.
'Don't give him any ideas,' she said.
Associate opinion editor Ned Barnett can be reached at 919-404-7583, or nbarnett@newsobserver.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
6 minutes ago
- Newsweek
Marjorie Taylor Greene Fumes Over Vaccine Approval: 'Not MAHA at All'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Marjorie Taylor Greene has spoken out against a new COVID-19 vaccine being approved in the United States, saying the move is "not MAHA at all." Why It Matters Health Secretary Robert F. Kennedy Jr. is facing repeated backlash for some of his positions on health and medicine, including from people who would ordinarily support him. In May, prominent members of the Make America Great Again movement, including Nicole Shanahan, Kennedy's former presidential running mate, and media personality Laura Loomer, spoke out against Kennedy Jr.'s pick for U.S. Surgeon General Casey Means. In March, Kennedy Jr. sparked anger from anti-vax activists when he called on parents to "consult with their healthcare providers to understand their options to get the MMR vaccine," with one saying he is "no different than Fauci." Marjorie Taylor Greene, R-Ga., arrives for a meeting of House Republicans in the Capitol Visitor Center on May 15, 2025. Marjorie Taylor Greene, R-Ga., arrives for a meeting of House Republicans in the Capitol Visitor Center on May 15, 2025. AP What To Know The U.S. Food and Drug Administration (FDA) gave the green light for mNEXSPIKE (mRNA-1283), Moderna's new lower-dose COVID-19 vaccine, on May 31. Greene, the U.S. representative for Georgia's 14th congressional district, shared Moderna's post about the recent approval with the caption: "Not MAHA at all!!! Unreal." Not MAHA at all!!! Unreal. — Rep. Marjorie Taylor Greene🇺🇸 (@RepMTG) June 1, 2025 She was referring to Kennedy Jr.'s movement Make America Healthy Again, whose mission is to "aggressively combat the critical health challenges facing our citizens, including the rising rates of mental health disorders, obesity, diabetes, and other chronic diseases." Newsweek has contacted the United States Department of Health and Human Services outside of office hours, via email, for comment. The new vaccine is set to be used for adults 65 or older or people between the ages of 12 and 64 with at least one or more underlying risk factor as defined by the Centers for Disease Control and Prevention (CDC). Approval for the jab is "based on results from a randomized, observer-blind, active-controlled Phase 3 clinical trial which enrolled approximately 11,400 participants aged 12 years and older," Moderna says. It comes after Kennedy Jr. announced that the CDC is no longer encouraging COVID-19 vaccines for pregnant women and healthy children, marking a shift in federal public health guidance. What People Are Saying Chief Executive Officer of Moderna Stéphane Bancel said in a statement: "The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19. "COVID-19 remains a serious public health threat, with more than 47,000 Americans dying from the virus last year alone. We appreciate the FDA's timely review and thank the entire Moderna team for their hard work and continued commitment to public health." Kennedy Jr. said about the new CDC guidance: "I couldn't be more pleased to announce that as of today the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule." What Happens Next The new vaccine is expected to be ready for those eligible to take it in time for the 2025-2026 respiratory virus season. You should not get mNEXSPIKE if you had a severe allergic reaction after a previous dose of either mNEXSPIKE, SPIKEVAX (an mRNA vaccine for preventing COVID-19) or any Moderna COVID-19 vaccine or to any ingredient in these vaccines, the company warns.

Wall Street Journal
14 minutes ago
- Wall Street Journal
Podcast: Trump's Plan B After Trade Court Setback
Last week, an obscure trade court dropped a bombshell ruling: President Trump didn't have the authority to issue sweeping tariffs under a 1977 law. The government has appealed the court's decision. WSJ's James Fanelli and Gavin Bade dig into the ruling and what it could mean for the future of Trump's trade agenda. Annie Minoff hosts. 🎧 Listen here to The Journal podcast.

Wall Street Journal
19 minutes ago
- Wall Street Journal
Global Markets, U.S. Futures Lower on Trade Tensions
Global stocks and U.S. futures started the new month lower after President Trump threatened to double tariffs on steel and aluminum, and trade tensions escalated between China and the U.S. Late Friday, Trump said he would increase tariffs on steel and aluminum up to 50%, starting Wednesday. The president also accused China of breaking a trade truce agreed in mid-May, which China has denied.